5 Key Takeaways
-
1
BVI's Finevision HP trifocal intraocular lens has received FDA approval.
-
2
The lens incorporates BVI’s proprietary POD platform and CoPODize technology.
-
3
Its design features a double C-loop, 4-point haptic for stability and centration.
-
4
The FDA approval supports BVI's mission for best-in-class visual outcomes globally.
-
5
Finevision HP will be showcased at the AAO Annual Meeting in Orlando, Florida.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







